CTOS 2022 - Connective Tissue Oncology Society 2022 Annual Meeting
Nov 16 - Nov 19, 2022 | VancouverCanada
LARVOL is not affiliated with Connective Tissue Oncology Society 2022 Annual Meeting and all trademarks, logos, and brand names are property of their respective owners
Showing 70 abstracts linked to Trials
A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
PALBOSARC: A PHASE II TRIAL OF PALBOCICLIB IN ADVANCED SARCOMA OVEREXPRESSING CDK4 GENE EXCLUDING DEDIFFERENTIATED LIPOSARCOMA (DD LPS): A STUDY FROM THE SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS).
TRABECTEDIN WITH CONCOMITANT RADIATION THERAPY FOR PATIENTS WITH RESECTABLE RETROPERITONEAL LIPOSARCOMA OR LEIOMYOSARCOMA: A PHASE I/II TRIAL OF SPANISH (GEIS), ITALIAN (ISG) AND FRENCH (FSG) GROUPS
P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA